{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:32:59Z","timestamp":1754483579080},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Adult-onset hepatitis B virus-associated membranoproliferative glomerulonephritis (HBV-MPGN) is generally refractory, and an effective treatment for this condition has not been established. The indications for steroids in HBV-MPGN are an important clinical concern.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 28-year-old woman with a chronic hepatitis B virus infection developed nephrotic syndrome in her second month of pregnancy, with urinary protein levels of 3 to 10\u200ag\/d that continued into her postpartum period. She was a carrier of HBV with HBeAg seroconversion. As her renal impairment could have been a result of pregnancy, we observed her for 10 months postpartum without any intervention. However, spontaneous remission after childbirth was not achieved and urine protein levels were sustained at 1 to 3\u200ag\/d. About 10 months after delivery, elevated serum liver enzyme levels were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Biopsies showed MPGN, with deposition of hepatitis B antigen in the glomeruli, and chronic B-type hepatitis with a severity grade of A1F0. She was diagnosed with HBV-MPGN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was started on entecavir 0.5\u200amg\/d in March 2008. Within 1 month, serum HBV DNA became undetectable; within 3 months, her alanine aminotransferase levels normalized. However, urinary protein excretion did not decrease to &lt;2\u200ag\/d. On a second renal biopsy, performed 7 months after entecavir treatment, proliferative lesions of the glomeruli were observed; therefore, prednisolone was started at an initial dose of 30\u200amg\/d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Her proteinuria improved immediately and prednisolone was tapered over 10 months. A third renal biopsy showed a remarkable resolution of HBV-MPGN, with a significant decrease in mesangial proliferation and immune complex deposition. HBV reactivation was not observed during the prednisolone treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Additional prednisolone therapy in combination with antiviral therapy should be considered for refractory HBV-MPGN, with sufficient care taken regarding HBV reactivation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014014","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T13:07:26Z","timestamp":1548335246000},"page":"e14014","source":"Crossref","is-referenced-by-count":6,"title":["Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis"],"prefix":"10.1097","volume":"98","author":[{"given":"Hiroshi","family":"Kataoka","sequence":"first","affiliation":[{"name":"Department of Medicine Kidney Center"},{"name":"Clinical Research Division for Polycystic Kidney Disease, Department of Medicine, Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"},{"name":"Clinical Research Division for Polycystic Kidney Disease, Department of Medicine, Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Akihisa","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kawasoe","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kawachi","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Makabe","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anri","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"},{"name":"Department of Surgical Pathology, Tokyo Women's Medical University, Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Manabe","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Amemiya","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Mitobe","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Akanuma","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, Kameda Medical Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, Kameda Medical Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, Kameda Medical Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuomi","family":"Matsui","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Moriyama","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Horita","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamiko","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Nephrology & Hypertension, Kameda Medical Center, Chiba"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuho","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Showa University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Medicine Kidney Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"(suppl)","key":"R3-20230928","doi-asserted-by":"crossref","first-page":"S765","DOI":"10.1093\/infdis\/jix356","article-title":"Immunopathogenesis of Hepatitis B Virus","volume":"216","author":"Tseng","year":"2017","journal-title":"J Infect Dis"},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ki.1990.32","article-title":"Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations","volume":"37","author":"Johnson","year":"1990","journal-title":"Kidney Int"},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000077065","article-title":"Hepatitis B virus-associated nephropathy","volume":"24","author":"Bhimma","year":"2004","journal-title":"Am J Nephrol"},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2036.2006.03041.x","article-title":"Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"e0160437","DOI":"10.1371\/journal.pone.0160437","article-title":"A meta-analysis of antiviral therapy for Hepatitis B virus-associated membranous nephropathy","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1743-422X-9-200","article-title":"The relationship between HBV serum markers and the clinicopathological characteristics of hepatitis B virus-associated glomerulonephritis (HBV-GN) in the northeastern chinese population","volume":"9","author":"Zhang","year":"2012","journal-title":"Virol J"},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/hep.29323","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"66","author":"Lok","year":"2017","journal-title":"Hepatology"},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"619.e1","DOI":"10.1053\/j.gastro.2012.05.037","article-title":"Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B","volume":"143","author":"Lok","year":"2012","journal-title":"Gastroenterology"},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"c41","DOI":"10.1159\/000324652","article-title":"Treatment of hepatitis B virus-associated nephropathy","volume":"119","author":"Elewa","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3748\/wjg.v18.i8.821","article-title":"Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis","volume":"18","author":"Zheng","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/ki.1988.215","article-title":"A renal biopsy study of hepatitis B virus-associated nephropathy in Korea","volume":"34","author":"Lee","year":"1988","journal-title":"Kidney Int"},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00868249","article-title":"The clinical course of hepatitis B virus-associated nephropathy","volume":"8","author":"Gilbert","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/adc.58.7.488","article-title":"Hepatitis B virus associated membranous glomerulonephritis","volume":"58","author":"Wiggelinkhuizen","year":"1983","journal-title":"Arch Dis Child"},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","author":"Lai","year":"1991","journal-title":"N Engl J Med"},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00860947","article-title":"Resolution of hepatitis B virus-related membranoproliferative glomerulonephritis after orthotopic liver transplantation","volume":"9","author":"Quan","year":"1995","journal-title":"Pediatr Nephrol"},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1093\/ndt\/gfr139","article-title":"Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy","volume":"26","author":"Kataoka","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000486931","article-title":"Large renal corpuscle: clinical significance of evaluation of the largest renal corpuscle in kidney biopsy specimens","volume":"195","author":"Kataoka","year":"2018","journal-title":"Contrib Nephrol"},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1681\/ASN.2014040406","article-title":"C4d as a diagnostic tool in proliferative GN","volume":"26","author":"Sethi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Spanish Group for Study of Glomerular Diseases (GLOSEN). Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-20230928","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trre.2009.02.005","article-title":"Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant Rev (Orlando)"},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep.20891","article-title":"Mannose-binding lectin in chronic hepatitis B virus infection","volume":"42","author":"Chong","year":"2005","journal-title":"Hepatology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901110-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:19:42Z","timestamp":1695871182000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901110-00043"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014014","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}